GlassScriptPhysician profile
Anthony A Holden
NPI 1720086606
$24,109.18
in general payments reported to CMS, 2019-2025
21 companies · $795 in 2025
The $795 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $277 · 2020: $1,438 · 2021: $14K · 2022: $2,429 · 2023: $360 · 2024: $4,614 · 2025: $795.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Food and Beverage: $1,672 · Travel and Lodging: $1,597.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Food and Beverage | $1,672.39 |
| Travel and Lodging | $1,596.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $19,054.14 | 2020-2024 | Da Vinci Surgical System |
| Abiomed | $1,538.99 | 2019-2025 | Impella |
| Atricure, INC. | $999.56 | 2020-2025 | Atriclip Laa Exclusion System, Atricure Cryoice Cryoablation System (Cryo2) |
| Zimmer Biomet Holdings, INC. | $575.87 | 2020-2025 | A&E Medical / Sternalock Xp Rigid Fixation System, Sternalock Blu System |
| Artivion, INC. | $436.21 | 2022-2025 | Bioglue Surgical Adhesive, On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Cardiac Non-Synergraft |
| Edwards Lifesciences Corporation | $425.87 | 2021-2023 | Mitris Resilia Mitral Valve |
| Galvanize Therapeutics, INC | $198.98 | 2025 | Aliya System |
| Angiodynamics, INC. | $170.62 | 2020-2025 | Angiovac |
| Abbott Laboratories | $158.37 | 2021-2022 | |
| Smith+Nephew, INC. | $108.43 | 2024 | Stravix, Stravix Mesh |
| Regeneron Healthcare Solutions, INC. | $94.86 | 2023-2024 | Libtayo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $88.11 | 2019 | |
| Baxter Healthcare | $61.43 | 2024 | Floseal |
| Ethicon INC. | $44.87 | 2021 | |
| Elutia, INC. | $30.24 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Getinge USA Sales, LLC | $25.45 | 2022 | |
| Octapharma USA, INC. | $24.89 | 2025 | Fibryga |
| Medtronic Vascular, INC. | $23.66 | 2019 | |
| Kls-Martin L.P. | $16.59 | 2025 | |
| La Jolla Pharmaceutical Company | $16.34 | 2023 | Giapreza |
| Janssen Pharmaceuticals, INC | $15.70 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Holden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.